ESR1 and triple-negative breast carcinoma: (173) observed increased levels of ROS in cell lines of triple-negative breast cancer (TNBC) and dependency on ROS for survival as antioxidant treatment induced cell death in TNBC cells but not in an estrogen receptor-positive (ER+) cell line.